Approvals/TGA/SITAGLIPTIN MYLAN sitagliptin (as hydrochloride monohydrate) 100 mg tablet blister pack

Approved

STANDARD

SITAGLIPTIN MYLAN sitagliptin (as hydrochloride monohydrate) 100 mg tablet blister pack

Maple Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 235756731ef50c38
Product Name: SITAGLIPTIN MYLAN sitagliptin (as hydrochloride monohydrate) 100 mg tablet blister pack
Artg Id: 384802
Artg Name: SITAGLIPTIN MYLAN sitagliptin (as hydrochloride monohydrate) 100 mg tablet blister pack
Sponsor: Maple Healthcare Pty Ltd
Company Detail Path: /organization/maple-healthcare-pty-ltd
Artg Date: 2023-04-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-02054-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01620-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

235756731ef50c38

Type

Standard